Action of the muscarinic toxin MT7 on agonist-bound muscarinic M 1 receptors

European Journal of Pharmacology

Volumn 487, Issue 1-3, 2004, Pages 65-72

  Olianas, Maria C ^a   Adem, Abdu ^b   Karlsson, Evert ^c   Onali, Pierluigi ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

35S GTP S binding; 3H Acetylcholine binding; 3H N Methyl scopolamine binding; Dendroaspis angusticeps toxins; Muscarinic M1 receptor; Phosphoinositide hydrolysis

Indexed keywords

ACETYLCHOLINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INOSITOL PHOSPHATE; MEMBRANE PROTEIN; MUSCARINIC M1 RECEPTOR; MUSCARINIC TOXIN 7; RADIOLIGAND; SULFUR 35; TOXIN; TRITIUM; UNCLASSIFIED DRUG;

AGONIST; ANIMAL CELL; ARTICLE; BINDING ASSAY; CHO CELL; CONTROLLED STUDY; DISSOCIATION; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SCREENING; EXPERIMENT; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; STIMULATION; TIME;

ACETYLCHOLINE; ANIMALS; CELL MEMBRANE; CHO CELLS; CHOLINERGIC AGENTS; CLONING, MOLECULAR; CRICETINAE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; INOSITOL PHOSPHATES; MUSCARINIC AGONISTS; N-METHYLSCOPOLAMINE; PARASYMPATHOLYTICS; RECEPTOR, MUSCARINIC M1;

EID: 1642408678     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.01.029     Document Type: Article

References (35)

1. Adem A., Karlsson E. Muscarinic receptor subtype selective toxins. Life Sci. 60:1997;1069-1076.
2. Berridge M.J., Dawson R.M.C., Downes C.P., Heslop J.P., Irvine R.F. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J. 212:1983;473-482.
3. Birdsall N.J.M., Lazareno S., Popham A., Saldanha J. Multiple allosteric sites on muscarinic receptors. Life Sci. 2001;2517-2524.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Bradley K.N. Muscarinic toxins from the green mamba. Pharmacol. Ther. 85:2000;87-109.
6. Bradley K.N., Rowan E.G., Harvey A.L. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5 muscarinic receptors expressed in Chinese hamster ovary cells. Toxicon. 41:2003;207-215.
7. Carsi J.M., Potter L.T. m1-Toxin isotoxins from the green mamba (Dendroaspis angusticeps) that selectively block m1 muscarinic receptors. Toxicon. 38:2000;187-198.
8. Christopoulos A., Kenakin T. G protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54:2002;323-374.
9. Gilman A.G. G proteins: transducers of receptor-generated signals. Ann. Rev. Biochem. 56:1987;615-649.
10. 3H]acetylcholine to m2 muscarinic receptors. Biochem. Pharmacol. 52:1996;1767-1775.
11. 3H] acetylcholine and its modulation by transition metal ions and guanine nucleotides. Proc. Natl. Acad. Sci. U. S. A. 81:1984;3650-3654.
12. 3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides. Mol. Pharmacol. 28:1985;297-305.
13. Harden T.K., Meeker R.B., Martin M.W. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors. J. Pharmacol. Exp. Ther. 227:1983;570-577.
14. Hulme E.C., Berrie C.P., Birdsall N.J.M., Jameson M., Stockton J.M. Regulation of muscarinic agonist binding by cations and guanine nucleotides. Eur. J. Pharmacol. 94:1983;59-72.
15. Jerusalinsky D., Harvey A.L. Toxins from mamba venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 15:1994;424-430.
16. Jolkkonen, M., 1996. Muscarinic toxins from Dendroaspis (mamba) venom. Acta Univ. Uppsala, Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 183. Uppsala, Sweden.
17. Karlsson E., Jolkkonen M., Mulugeta E., Onali P., Adem A. Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors. Biochimie. 82:2000;793-806.
18. Krajewski J.L., Dickerson I.M., Potter L.T. Site-directed mutagenesis of m1-Toxin1: two amino acids responsible for stable binding to M1 muscarinic receptors. Mol. Pharmacol. 60:2001;725-731.
19. Leppik R.A., Birdsall N.J.M. Agonist binding and function at the human α2A-adrenoceptor: allosteric modulation by amilorides. Mol. Pharmacol. 58:2000;1091-1099.
20. Leppik R.A., Lazareno S., Mynett A., Birdsall N.J.M. Characterization of the allosteric interactions between antagonists and amiloride analogues at the human α2A-adrenergic receptor. Mol. Pharmacol. 53:1998;916-925.
21. Liang J., Gutierrez-Ford C., Potter L.T. Sustained unilateral blockade of rat striatal muscarinic receptors with m1-toxin1 in vivo. Brain Res. 921:2001;211-218.
22. Marino M., Rouse S.T., Levey A.I., Potter L.T., Conn P.J. Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc. Natl. Acad. Sci. U. S. A. 95:1998;11465-11470.
23. Max S.I., Liang J.-S., Potter L.T. Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol. Pharmacol. 44:1993;1171-1175.
24. McPherson G.A. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J. Pharmacol. Methods. 14:1985;213-228.
25. Mourier G., Dutertre S., Fruchart-Gaillard C., Menez A., Servent D. Chemical synthesis of MT1 and MT7 muscarinic toxins : critical role of Arg-34 in their interaction with M1 muscarinic receptor. Mol. Pharmacol. 63:2003;26-35.
26. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for the characterization of the ligand-binding systems. Anal. Biochem. 107:1980;220-239.
27. 3H]cis- methyldioxolane binding to guanyl nucleotide-sensitive sites. Mol. Pharmacol. 24:1983;366-373.
28. Olianas M.C., Maullu C., Adem A., Mulugeta E., Karlsson E., Onali P. Inhibition of acetylcholine muscarinic M1 receptor function by the M1-selective ligand muscarinic toxin 7 (MT-7). Br. J. Pharmacol. 131:2000;447-452.
29. Onali P., Olianas M.C. Muscarinic M4 receptor inhibition of dopamine D1-like receptor signalling in rat nucleus accumbens. Eur. J. Pharmacol. 448:2002;105-111.
30. Potter L.T. Snake toxins that bind specifically to individual subtypes of muscarinic receptors. Life Sci. 68:2001;2541-2547.
31. Rouse S.T., Hamilton S.E., Potter L.T., Nathanson N.M., Conn P.J. Muscarinic-induced modulation of potassium conductances is unchanged in mouse hippocampal pyramidal cells that lack functional M1 receptors. Neurosci. Lett. 278:2000;61-64.
32. Tucek S., Proska J. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16:1995;205-212.
33. Vandermeers A., Vandermeers-Piret M.-C., Rathe' J., Waelbroeck M., Jolkkonen M., Oras A., Karlsson E. Purification and sequence determination of a new muscarinic toxin (MT4) from the venom of the green mamba (Dendroaspis angusticeps). Toxicon. 33:1995;1171-1179.
34. Vickroy T.W., Yamamura H.I., Roeske W.R. Differential regulation of high-affinity agonist binding to muscarinic sites in the rat heart, cerebellum, and cerebral cortex. Biochem. Biophys. Res. Commun. 116:1983;284-290.
35. Waelbroeck M., Robberecht P., Chatelain P., Christophe J. Rat cardiac muscarinic receptors: I. Effects of guanine nucleotides on high- and low-affinity binding sites. Mol. Pharmacol. 21:1982;581-588.